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Available online 2 June 2014Parkinson's disease (PD), caused by selective loss of dopaminergic (DA) neurons in the substantia nigra, is the
most common movement disorder with no cure or effective treatment. Exposure to the mitochondrial complex
I inhibitor rotenone recapitulates pathological hallmarks of PD in rodents and selective loss of DA neurons in
Drosophila. However, mechanisms underlying rotenone toxicity are not completely resolved. We previously re-
ported a neuroprotective effect of human uncoupling protein 2 (hUCP2) against rotenone toxicity in adult ﬂy
DA neurons. In the current study, we show that increased mitochondrial fusion is protective from rotenone tox-
icity whereas increased ﬁssion sensitizes the neurons to rotenone-induced cell loss in vivo. In primary DA neu-
rons, rotenone-induced mitochondrial fragmentation and lethality is attenuated as the result of hucp2
expression. To test the idea that the neuroprotective mechanism of hUCP2 involves modulation of mitochondrial
dynamics, we detect preserved mitochondrial network, mobility and fusion events in hucp2 expressing DA neu-
rons exposed to rotenone. hucp2 expression also increases intracellular cAMP levels. Thus, we hypothesize that
cAMP-dependent protein kinase (PKA) might be an effector that mediates hUCP2-associated neuroprotection
against rotenone. Indeed, PKA inhibitors block preserved mitochondrial integrity, movement and cell survival
in hucp2 expressing DA neurons exposed to rotenone. Taken together, we present strong evidence identifying
a hUCP2-PKA axis that controls mitochondrial dynamics and survival in DA neurons exposed to rotenone impli-
cating a novel therapeutic strategy in modifying the progression of PD pathogenesis.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Epidemiological studies suggested pesticide exposure as a risk factor
for the sporadic form of Parkinson's disease (PD), which constitutes
over 90% of all PD cases (Banerjee et al., 2009; Liou et al., 1997;
Sanders and Timothy Greenamyre, 2013). In a rodent PD model, intra-
peritoneal injection of the mitochondrial complex I inhibitor rotenone,
found in common pesticides resulted in PD-like motor defects, loss of
dopaminergic (DA) neurons and α-synuclein and poly-ubiquitin posi-
tive aggregates in DA neurons (Cannon et al., 2009), notwithstanding
previous controversial ﬁndings under similar treatment conditionsD, Parkinson's disease; DA, do-
se.
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. This is an open access article under(Fleming et al., 2004; Hoglinger et al., 2003; Zhu et al., 2004). In Dro-
sophila, long-term exposure to rotenone leads to selective DA neurode-
generation and the loss of climbing ability that is alleviated by L-DOPA
ingestion (Coulom and Birman, 2004). As rotenone induces key PD fea-
tures in both vertebrate and invertebrate model systems, its toxicity is
generally thought to involve mitochondrial dysfunction and oxidative
stress (Hisahara and Shimohama, 2010). Consistentwith its role as ami-
tochondrial complex I inhibitor, rotenone exerts its neurotoxicity
through oxidative stress (Panov et al., 2005; Sherer et al., 2003a) and
energy depletion (Yadava andNicholls, 2007). Seemingly not connected
to the disruption of mitochondrial respiration: microtubule disruption
(Choi et al., 2011) andmicroglial activation (Gao et al., 2002) are also at-
tributable to rotenone toxicity. Controversy remains as towhether com-
plex I inhibition is required for rotenone toxicity in DA neurons (Choi
et al., 2008; Marella et al., 2008).
Mitochondrial fusion andﬁssion are dynamic processes that regulate
themorphology, distribution, function and turnover of those organellesthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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(Opa1), two proteins drivingmitochondrial outer and inner membrane
fusion are associated with the neurodegenerative diseases Charcot-
Marie-Tooth type 2A and dominant optic atrophy, respectively
(Alexander et al., 2000; Delettre et al., 2000). Similarly, perturbation in
mitochondrial ﬁssion protein dynamin-related protein 1 (Drp1) in hip-
pocampal neurons reduces dendritic spine growth and synaptic plastic-
ity (Li et al., 2004). Mitochondrial ﬁssion mediates 1-methyl-4-
phenylpyridinium (MPP+) toxicity (Wang et al., 2011) whereas expo-
sure to rotenone results in mitochondrial fragmentation, autophagic
turnover of mitochondria and cell death (Barsoum et al., 2006; Chu
et al., 2013). Drp1 is intimately associated with the apoptotic process
(Arnoult, 2007) in which Drp1-mediated mitochondrial fragmentation
augments the release of cytochrome C from mitochondria, an early
step in apoptosis (Cassidy-Stone et al., 2008). As a major regulator of
Drp1 activity, cAMP-dependent protein kinase (PKA) phosphorylates
Drp1 and leads to its cytosolic sequestration promoting an elongated
mitochondrial network (Cereghetti et al., 2008; Chang and Blackstone,
2007; Cribbs and Strack, 2007). A neuroprotective role of PKA phos-
phorylation of Drp1 has been suggested as constitutive Drp1 phosphor-
ylation at the consensus PKA site inhibits cytochrome C release and
apoptosis in neuronal PC12 cells (Cribbs and Strack, 2007). Further-
more, PKA targeted to mitochondria through the scaffold protein A ki-
nase anchoring protein 1 (AKAP1) exerts neuroprotection against
PINK1 deﬁciency in a cellular PD model by phosphorylating Drp1 and
blunting its ﬁssion activity (Dagda et al., 2011; Merrill et al., 2011).
These ﬁndings suggest that PKA exerts its protective effect by control-
ling mitochondrial shape and subsequent function through attenuation
of mitochondrial ﬁssion. While excess mitochondrial ﬁssion increases
reactive oxygen species (ROS), disrupts calcium homeostasis, impairs
mitochondrial respiratory capacities and facilitates many forms of apo-
ptosis (Chan, 2006), the inﬂuence of mitochondrial dynamics on toxin-
induced DA neurodegeneration in vivo has not been reported.
Neuronal uncoupling proteins (UCP2, UCP4 and UCP5) promote sur-
vival in the CNS (Andrews et al., 2005a). In the brain, UCPs are thought
to exert a cytoprotective effect through dissipation of the proton gradi-
ent generated during substrate oxidation. This results in decreased
protonmotive force leading to a reduced mitochondrial ROS production
while maintaining long-term ATP homeostasis (Andrews et al., 2005a;
Azzu et al., 2010). Consistent with its expression in the substantia
nigra, UCP2 activity is involved inmaintaining nigrostriatal DA neuronal
function (Andrews et al., 2005b). Interestingly, although reduced oxida-
tive stress is associatedwith its protective effect in cellmodels, UCP2 ac-
tivity in catecholaminergic neurons protectsMPP+-inducedDAneuron
loss but not toxin associated oxidative damage (Conti et al., 2005). Thus,
additional mechanisms are likely involved in UCP2-mediated DA
neuroprotection.
We previously reported that targeted hucp2 expression under the
control of the tyrosine hydroxylase (TH) promoter has a neuroprotec-
tive effect against rotenone-induced DA neuron loss (Islam et al.,
2012). To examine the hUCP2 protectivemechanism,we developed pri-
mary DA neuronal cultures from midgastrula embryos and recapitulat-
ed the hUCP2 protective effect against rotenone in vitro. Furthermore,
we demonstrated that increased expression of themitochondrialﬁssion
molecule Drp1 sensitized brain DA neurons to rotenone toxicity and
overexpression of mitochondrial fusion molecules Marf (Drosophila ho-
mologue for Mfn) or Opa1 protected those neurons from rotenone tox-
icity. Rotenone-induced mitochondrial fragmentation was detected in
primary DA neurons, so we investigated whether the protective effect
of hUCP2 involved mitochondrial remodeling. In genetic interaction
studies, we detected a rough eye phenotype only when hucp2 is co-
expressed with Marf or Opa1 whereas no such additive effect was
observed as the result of co-expression of hucp2 and drp1, suggesting
functional cooperation between hUCP2 and mitochondrial fusion path-
ways. Consistentwith the genetic interaction study,we foundpreserved
mitochondrial morphology, mobility, and fusion events in hucp2expressing but not control primary DA neurons exposed to rotenone.
In brain DA neurons, heightened sensitivity to rotenone toxicity from
drp1 overexpressionwas rescued by the expression of hucp2, further in-
dicating a role of hUCP2 in countering mitochondrial ﬁssion. Based on
these results, we hypothesized that, when cells are stressed with rote-
none treatment, hUCP2 activity modulates mitochondrial bioenergetics
to trigger cAMP-dependent PKAactivity leading to decreasedmitochon-
drial ﬁssion and increased cell survival. In support of this idea, we de-
tected elevated cAMP levels in Drosophila S2R+ cells harboring
hUCP2 activity. Also, elongated mitochondria and increased mitochon-
drial mobility were measured in primary neurons exposed to forskolin,
a PKA activator. Consistent with our hypothesis, we show that pre-
served mitochondrial length, mobility, fusion events, and survival in
hucp2 expressing neurons exposed to rotenone were abrogated in the
presence of two independent PKA inhibitors. Our results point to a
hUCP2-PKA axis in preserving mitochondrial integrity and mobility as
well as enhancing cell survival to counter rotenone toxicity.
Results
The mitochondrial fusion/ﬁssion machinery modiﬁes rotenone-induced
brain DA neuron loss
Blocking mitochondrial ﬁssion attenuates rotenone-induced apo-
ptosis in primary cortical neurons (Barsoum et al., 2006). However,
the impact ofmitochondrial fusion/ﬁssion regulation on rotenone toxic-
ity in vivo has not been described. To begin our investigation into the
cellular mechanism underlying the protective effect of hUCP2 against
rotenone in brain DA neurons, we asked whether rotenone toxicity
could be modulated by mitochondrial dynamics in vivo. To address
this question, we used the well-established UAS/Gal4 expression sys-
tem to increase the expression of mitochondrial fusion or ﬁssion mole-
cules in brain DA neurons with the THNGFP driver where co-expression
of GFP in the same neurons allowed the quantiﬁcation of rotenone-
induced cell loss (Islam et al., 2012; Park et al., 2007). Several UAS
lines previously shown to overexpress mitochondrial ﬁssion molecule
Drp1, its dominant negative version (Drp1K38A) aswell asmitochondrial
fusion proteins Marf or Opa1 were employed in our study (Park et al.,
2009).We independently veriﬁed the overexpression status of each tar-
get gene in the heads of these ﬂies after crossing to the THNGFP driver
(Supplemental Fig. 1). To assess rotenone-induced neurodegeneration,
we quantiﬁed the number of DA neurons in the protocerebral posterior
1 (PPL1) cluster in each brain hemisphere (Ng et al., 2012). As shown in
Fig. 1, there was a 29% loss in DA neurons in control ﬂies as the result of
rotenone exposure. Interestingly, drp1 expression sensitized DA neu-
rons to rotenone toxicity, causing a 58% loss of those neurons. In con-
trast, promoting mitochondrial fusion with the expression of Marf or
Opa1 protected DA neurons from rotenone toxicity (Fig. 1B; PPL1 neu-
ron numbers: control 11.1 ± 0.22; control + rot 7.9 ± 0.49; Drp1 10 ±
0.39; Drp1 + rot 4.2 ± 0.74; Marf 10.1 ± 0.53; Marf + rot 9.7 ± 0.9;
Opa1 10.6 ± 0.65; Opa1 + rot 11 ± 1, N = 15–20). Furthermore,
blocking mitochondrial ﬁssion with the dominant negative form of Drp1,
Drp1K38A also rendered DA neurons more resistant to rotenone toxicity
(data not shown). Taken together, these results demonstrate that the
mitochondrial fusion/ﬁssionmachinery plays an important role inmod-
ulating rotenone toxicity in DA neurons, with mitochondrial fusion
being protective and mitochondrial ﬁssion exacerbating rotenone
toxicity.
hucp2 expression protects against rotenone-induced mitochondrial
fragmentation and lethality in primary DA neurons
We recently reported that a signiﬁcant protection against rotenone-
induced brain DAneuron loss is achieved in THNhUCP2ﬂies (Islam et al.,
2012). Based on our in vivoﬁndings that increasedmitochondrialﬁssion
exacerbated rotenone toxicity, we reasoned that mitochondrial
Fig. 1. The mitochondrial fusion/ﬁssion machinery modiﬁes rotenone toxicity in brain DA neurons. (A) Representative images of the GFP + DA neurons of the PPL1 cluster from whole
mount adult brains following rotenone (Rot) treatment at 500 μM for 4 days. Scale bar= 10 μm. (B) Quantiﬁcation of GFP+ DA neurons of the PPL1 cluster demonstrates that increased
expression of mitochondrial ﬁssion molecule exacerbates rotenone toxicity whereas increased expression of mitochondrial fusion molecules is protective. Scoring of the DA neurons was
carried out in a “blind” fashion as previously described (Islam et al., 2012). Each bar represents average± S.E.M. P valueswere calculated by Student's t test. N= 15–20 brains/condition.
Cont: THNUAS-GFP, w1118; Drp1: THNUAS-GFP, UAS-drp1; Marf: THNUAS-GFP, UAS-Marf; and Opa1: THNUAS-GFP, UAS-Opa1.
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posed to rotenone. To test this idea, we established primary Drosophila
DA neuronal cultures from midgastrula embryos to characterize in de-
tail mitochondrial dynamics. We show that rotenone elicited dose-
dependent lethality of primary DA neurons (Fig. 2A) and this lethality
was attenuatedwith hucp2 expression,where a 30% increase in survival
was measured as compared to control neurons, recapitulating hUCP2
neuroprotective effect in vivo (Fig. 2B) (Islam et al., 2012). To determine
whether hUCP2 has a pro-survival activity, we also quantiﬁed TH+
neurons in control and hucp2 expressing neurons under similar cultur-
ing conditions with the exception of rotenone exposure. As shown in
Fig. 2C, similar TH+ neuron numbers were counted in control or
hucp2 expressing neurons suggesting the hUCP2 neuroprotective effect
against rotenone lethality is not the result of a better survival in hucp2
expressing neurons.
While rotenone was shown to induce mitochondrial impairment in
cultured cortical neurons (Barsoum et al., 2006) and neuroblastoma
cells (Sherer et al., 2003b), its effect onmitochondrial integrity in prima-
ry DA neurons has not been characterized. To monitor mitochondrial
morphology,wemeasuredmitochondrial length in primary DAneurons
isolated from THNmitoGFP embryos in which mitochondria were GFP-
labeled (Yang et al., 2008). Following rotenone treatment,Fig. 2. Rotenone-induced primary DA neuron loss is attenuated as the result of hucp2 expressi
6 days, the number of TH+ neurons was normalized to 1000 DAPI+ cells and counted, sho
0.1 μM Rot: 2.55 ± 0.46; 0.5 μM Rot: 2.02 ± 0.26; 1 μM Rot: 1.7 ± 0.28). Each bar represents
neurons are protected from rotenone toxicity. Increased survival of hucp2 expressing DA neuro
lowing rotenone treatment/untreated neurons with the same genotype. Each bar represents av
not promote cell survival. Comparable numbers of control or hucp2 expressing DA neurons we
S.E.M. N = 27–65 images from 3 neuronal preparations. P values were calculated by Student'
follows: Cont: 808.59 ± 37.62 and hUCP2: 800.31 ± 37.53 indicating similar culturing conditimitochondrial length was quantiﬁed in neuritic projections. As shown
in Fig. 3, rotenone exposure resulted in mitochondrial fragmentation
where the average length of mitochondria in neuritic projections was
shortened by 18%.While only a non-signiﬁcant, small increase in the av-
erage mitochondrial length was detected in hucp2 expressing neurons
as compared to controls, hucp2 expressing neuronsweremore resistant
to rotenone induced mitochondrial fragmentation where the average
mitochondrial length measured in these neurons exposed to rotenone
was similar to that measured in control neurons (Fig. 3E; mitochondrial
length: control 1.71 μm± 0.06; control + rot 1.40 μm± 0.03; hUCP2
1.81 μm±0.1; hUCP2 + rot 1.93 μm±0.1, N = 32–40). These results
not only demonstrate rotenone-induced mitochondrial fragmentation
in primary DA neurons but also show that hUCP2 is protective against
rotenone in maintaining mitochondrial integrity.
Genetic interaction study indicates functional cooperation between hUCP2
and mitochondrial fusion molecules
Our studies in primary neuronal cultures demonstrated that mito-
chondria are more elongated in hucp2 expressing neurons as compared
to control neurons when exposed to rotenone. To explore the idea that
hUCP2 activitymight be involved in regulatingmitochondrial dynamics,on. (A) Rotenone induces DA neuron death. Following rotenone exposure (0.1–1 μM) for
wing a dose-dependent cell death as the result of rotenone exposure (Cont: 2.9 ± 0.51;
average ± S.E.M. N = 27–53 images from 3 neuronal preparations. (B) hucp2 expressing
ns as compared to control neurons wasmeasured as percentage of neurons remaining fol-
erage ± S.E.M. N= 72–79 images from 3 neuronal preparations. (C) hUCP2 activity does
re measured at 9 DIV (Cont: 2.9 ± 0.5; hUCP2: 3.0 ± 0.3). Each bar represents average ±
s t test. In these experiments, total numbers of DAPI + cells were determined at 9 DIV as
ons. Cont: THNUAS-GFP,w1118; hUCP2: THNUAS-GFP, UAS-hucp2.
Fig. 3. Rotenone-induced mitochondrial fragmentation is attenuated in primary DA neu-
rons harboring THNmitoGFP, hUCP2. (A–D) Representative images of mitochondrial mor-
phology in neuritic projections of control neurons (Cont) (A), control neurons treated
with rotenone (Cont + Rot) (B), hucp2 expressing neurons (hUCP2) (C) and hucp2 ex-
pressing neurons treated with rotenone (hUCP2 + Rot) (D) at 4 DIV. Scale bar = 5 μm.
(E) Quantiﬁcation of mitochondrial length under conditions A–D. Quantiﬁcation of mito-
chondrial length was carried out using the Image J tool (NIH) as described in Materials
and methods. Each bar represents average ± S.E.M. N = 32–40 images from 3 neuronal
preparations. P values were calculated by Student's t test. Not indicated in the graph:
the P value of Cont vs hUCP is 0.37 whereas the P value of Cont vs hUCP2+ Rot is 0.06.
Rotenone (Rot): 500 nM for 8 h.
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Gal4 driver to reveal any phenotypic changes in the Drosophila com-
pound eye as the result of co-expression of hucp2 andmitochondrialﬁs-
sion or fusionmolecules. Similar genetic epistatic analyses corroborated
a role of PINK1 in promoting mitochondrial ﬁssion (Poole et al., 2008)
and a functional relationship between Rhomboid-7, PINK1, Parkin and
the PD-linked mitochondrial serine protease Omi (Whitworth et al.,
2008). As shown in Fig. 4, expression of hucp2, drp1, Marf or Opa1
alone in the Drosophila eye rendered no discernible phenotype from
that of a control eye (Panels A–E). Interestingly, a rough eye phenotype
was detected when hucp2 and Marf are co-expressed (compare Panels
C&G) or when hucp2 and Opa1 were co-expressed (compare Panels
D&H). In contrast, no such additive phenotypic effect was detected
when hucp2 and drp1were co-expressed (compare Panels B&F). To fur-
ther corroborate those results, we used an RNAi approach to render a
pro-fusion environment by down-regulating drp1 and a pro-ﬁssion en-
vironment by down-regulatingMarf or Opa1, or via overexpression of
parkin or PINK1 (Park et al., 2009; Poole et al., 2008; Ziviani et al.,
2010). Down-regulation of target genes in THNDrp1RNAi, THNMarfRNAi
and THNOpa1RNAi ﬂies were veriﬁed (Supplemental Fig. 1). As shown
in Supplemental Fig. 2, co-expression of hucp2 and Drp1RNAi again re-
sulted in a rough eye phenotype whereas no such additive effect was
observed when hucp2 and MarfRNAi or hucp2 and Opa1RNAi were co-
expressed. Finally, co-expression of hucp2 and ﬁssion promoting mole-
cules parkin or PINK1 resulted in no additive eye phenotype. As these re-
sults strongly suggest functional cooperation between hUCP2 and
mitochondrial fusion pathways, we predicted similar mitochondrialmorphology in DA neurons expressing hucp2 or fusion molecules. To
test this possibility, we co-expressed mitoGFP with hucp2, Marf, Opa1
or drp1 using the THNmitoGFP driver and captured mitochondrial mor-
phology in brain DA neurons. Similar to the morphological changes re-
ported previously (Park et al., 2009; Yang et al., 2008), we detected
dispersed mitochondria in a tubular-like network in control or drp1 ex-
pressing brain DA neurons (Supplemental Figs. 3A and M). Distinctive
morphological alterations were observed upon expression of fusion
molecules Marf or Opa1 resulting in more fused, aggregate mitochon-
dria (Supplemental Figs. 3D and G). As predicted, when targeting
hUCP2 to TH+ neurons, mitochondrial morphology observed in these
neurons closely resembled that as the result ofMarf or Opa1 expression
(Supplemental Fig. 3J). While it is surprising that drp1 overexpression
does not result in obvious mitochondrial fragmentation, it is possible
that brain DA neurons are more sensitive to mitochondrial aggregation
as shown inMarf orOpa1 expressing neurons. Thus, in the absence of in-
creased expression of fusion proteins, mitochondria remain more dis-
persed, tubular shaped even under overexpression of a ﬁssion protein.
Nevertheless, these results suggest a role of hUCP2 in regulating mito-
chondrial morphology towards mitochondrial fusion.
hUCP2 activity rescues heightened rotenone sensitivity in drp1 expressing
brain DA neurons
The analysis of mitochondrial morphology in DA neurons suggested
an involvement of hUCP2 in promoting more fused mitochondria. This
notion is consistentwith the results showingmore elongatedmitochon-
dria in hucp2 expressing neurons than in control neurons exposed to ro-
tenone (Fig. 3). To further test the hypothesis that hUCP2 promotes
mitochondrial fusion or inhibits ﬁssion, we askedwhether hUCP2 activ-
ity would rescue the heightened rotenone sensitivity in DA neurode-
generation as the result of drp1 expression. Consistent with the results
shown in Fig. 1, drp1 expression rendered brain DA neurons more sen-
sitive to rotenone induced cell death as revealed by immunostaining of
whole mount brains with an anti-TH antibody (Fig. 5). Furthermore,
this effect was reversed as the result of hucp2 expression (Fig. 5E; PPL1
neuron numbers: control 10.8 ± 0.25; control + rot 8.31 ± 0.43;
Drp1 + rot 7.2 ± 0.32; hUCP2, Drp1 + rot 9.7 ± 0.13; N = 16–21).
These results suggest that hUCP2 activity counters increased sensitivity
to rotenone-induced DA cell loss as the result of drp1 overexpression.
Mitochondrial fusion events are preserved in DA neurons exposed to
rotenone as the result of hucp2 expression
Under rotenone treatment, more elongatedmitochondria measured
in hucp2 expressing neurons than in control neurons suggested in-
creased mitochondrial fusion or decreased ﬁssion. To distinguish be-
tween those two possibilities, we determined whether mitochondrial
fusion would be affected by hUCP2 activity in primary neurons exposed
to rotenone. We generated transgenic ﬂies harboring a mitochondrially
localized photo-convertible ﬂuorescent protein, MitoDendra2 (Wang
et al., 2008) and measured mitochondrial fusion events in primary DA
neurons co-expressing MitoDendra2 and hucp2. Following photo-
conversion, we counted the proportion of photo-converted mitochon-
dria undergoing fusion over time in primary DA neurons as previously
described where mitochondrial fusion events are deﬁned as diffusion
of red MitoDendra2 ﬂuorescence as one photo-converted mitochondri-
on fused to a non-converted one (Berman et al., 2009). As shown in
Fig. 6, we detected a large, 72% reduction in the proportion ofmitochon-
dria undergoing fusion events in control neurons treatedwith rotenone.
In contrast, diminished mitochondrial fusion events induced by rote-
none treatment were restored in hucp2 expressing neurons under the
same treatment condition (Fig. 6B; % photo-converted mitochondrial
undergoing fusion events: control 40.3 ± 2.1; control + rot 11.1 ±
3.2; hUCP2 + rot 48.3 ± 9.6; N = 74–84). These results clearly
Fig. 4. Rough eye phenotype as the result of co-expression of hucp2 and genes encoding mitochondrial fusion molecules. (A–E) Similar normal eye phenotype is observed in control
GMRNw1118 ﬂies and ﬂies expressing drp1 (GMRNUAS-drp1),Marf (GMRNUAS-Marf), Opa1 (GMRNUAS-Opa1) or hucp2 (GMRNUAS-hucp2) alone in the eye. (F) Co-expression of hucp2
and drp1 in the eye renders a similar, normal phenotype as seen when expressing each molecule alone (B, E). A rough eye phenotype is observed when co-expressing hucp2 andMarf
(G) or hucp2 and Opa1 (H). GMR: GMR-Gal4. Magniﬁcation = 100×.
184 R.-D. Hwang et al. / Neurobiology of Disease 69 (2014) 180–191demonstrate that rotenone-induced defects in mitochondrial fusion are
ameliorated as the result of hucp2 expression.
PKA activity is required for maintaining mitochondrial dynamics and
integrity in hucp2 expressing neurons exposed to rotenone
Our results show that promoting mitochondrial fusion through ex-
pression of fusion molecules is protective from rotenone's toxic effects
on DA neuron loss. Consistently, we show that hucp2 expressing DA
neuronsmaintain elongatedmitochondria, mitochondrial fusion eventsFig. 5. hucp2 expression rescues heightened sensitivity to rotenone-induced DA neuron loss in d
in control (A), control treatedwith rotenone (B), THNDrp1 treatedwith rotenone (C) and THNDr
antibody (ImmunoStar Inc., WI). Scale bar = 10 μm. (E) Quantiﬁcation of DA neurons in the PP
Scoring of theDAneuronswas carried out in a “blind” fashion and each bar represents average±
hUCP2, Drp1: THNUAS-drp1, UAS-hucp2.and are more resistant to rotenone-induced cell death as compared
to controls. To determine the underlying mechanisms affecting
mitochondrial dynamics in hucp2 expressing neurons, we considered
bioenergetic consequences as the result of increased mitochondrial
uncoupling. UCP uncouples substrate oxidation from ATP phosphoryla-
tion resulting in a decrease of intracellular ATP and an increase of both
cAMP and AMP levels (Galluzzi et al., 2011). Activation of cAMP-
dependent PKA was recently shown to promote elongated mitochon-
dria under starvation conditions through phosphorylation of Drp1
thereby preventing its translocation to mitochondria and execution ofrp1 overexpressing DA neurons. (A–D) Representative confocal images of the PPL1 cluster
p1, hUCP2 treatedwith rotenone (D)wholemount brains immunostainedwith an anti-TH
L1 cluster from whole mount brains under conditions A–D. N = 16–21 brains/condition.
SEM. P valueswere calculated by Student's t test. Control: THNw1118; Drp1: THNUAS-drp1;
Fig. 6.Mitochondrial fusion blocked by rotenone toxicity is restored as the result of hucp2 expression inprimaryDAneurons. (A) Representative time-lapse images ofmitochondrial fusion.
Mitochondria labeled with photo-convertible MitoDendra2 (Wang et al., 2008) were recorded for mitochondria fusion events in neurites of primary DA neurons pretreated with 500 nM
rotenone for 8 h at 4 DIV. Before photo-conversion (Pre),mitoDendra2 emits green ﬂuorescence. At time 0, selectedmitochondria (marked in squares)were exposed to laser at 405 nm for
photo-conversion from green to red ﬂuorescence. Following photo-conversion, time-lapse recordings of mitochondrial fusion events were collected for 30min. Note extended time-lapse
images shown for mitochondria of control neurons treated with rotenone to illustrate lack of mitochondrial fusion events. Scale bar = 5 μm. (B) The proportion of photo-converted mi-
tochondria under each treatment condition observed to undergo fusionwithin 30min (seeMaterial andmethods).Mitochondrial fusion events are deﬁned as diffusion of redﬂuorescence
as one converted mitochondrion fused to a non-converted one (Karbowski et al., 2004). Each bar represents average ± SEM. P values were calculated by Student's t test. N= 3–4 neuron
preparations with a total of 74–84 mitochondria selected. Cont: THNw1118, UAS-mitoDendra2; hUCP2: THNUAS-hucp2, UAS-mitoDendra2.
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hUCP2 and PKA activation, we asked if cytosolic cAMP levels could be
inﬂuenced by increased hUCP2 activity. To assess cellular cAMP levels
as the result of hucp2 expression, we adopted Drosophila S2R+ cells
to manipulate hUCP2 activity under the control of the copper inducible
metallothionein promoter (Barkus et al., 2008). As shown in Supple-
mental Fig. 4A, copper inducible expression of the hUCP2-GFP fusion
protein was detected in mitochondria of S2R+ cells. We next assessed
cAMP levels in the presence of the hUCP2-GFP fusion protein and mea-
sured a 67% increase in cytosolic cAMP levels in those cells as compared
to GFP expressing cells under copper induction (Supplemental Fig. 4B).
To demonstrate that the hUCP2-GFP fusion protein was fully functional,
we show that rotenone-induced membrane depolarization was largely
restored in S2R+ cells harboring the hUCP2-GFP fusion protein under
rotenone exposure (Supplemental Fig. 4C). These results provide critical
evidence placing PKA as a potential effector downstream of hUCP2
activity.
Next, we investigated whether PKA activation would regulate mito-
chondrial morphology and cell survival under rotenone treatment con-
ditions. Forskolin, an activator of adenylyl cyclase, stimulates PKA
activity by increasing intracellular cAMP levels (Dagda et al., 2011),
was used to elicit PKA activation in primary DA neurons. As shown in
Fig. 7, primary DA neurons pretreated with forskolin were signiﬁcantly
protected from rotenone inducedmitochondrial fragmentation (Fig. 7E;
mitochondrial length: control 1.71 μm ± 0.06; control + FSK
2.12 μm ± 0.09; control + rot 1.4 μm ± 0.03; control + FSK + rot
2.33 μm ±0.12, N = 31–42). Likewise, rotenone-induced cell death
was signiﬁcantly reduced as the result of forskolin pretreatment (Fig. 7
F; number of TH+ neurons/1000 cells: control: 4.1 ± 0.1; control +
rot: 1.9 ± 0.2; control + FSK + rot: 3.6 ± 0.3, N = 72–79). These
results demonstrate that a PKA activator preservesmitochondrial integ-
rity and survival to counter rotenone toxicity in DA neurons. To further
determinewhether mitochondrial lengthmaintained in forskolin treat-
ed neurons exposed to rotenone is associatedwith increasedmitochon-
drial fusion, we measured fusion events under these conditions. As
shown in Fig. 8A, pretreatmentwith forskolin substantially restoredmi-
tochondrial fusion events attenuated by rotenone treatment. Interest-
ingly, pre-treatment of hucp2 expressing neurons with H89, a PKA
inhibitor (Gomes et al., 2011) signiﬁcantly blocked the protective effect
on mitochondrial fusion events when exposed to rotenone by 56%
(Fig. 8A; % mitochondrial fusion events: control 40.3 ± 2.1; control +
rot 11.1 ± 3.2; control + FSK + rot 49 ± 7.9; hUCP2 + rot 48.3 ± 9.6hUCP2 + H89 + rot 21.7 ± 3.8; N = 75–84). Finally, corroborating
the ﬁndings that intact PKA activity is needed for maintaining mito-
chondrial fusion activity in hucp2 expressing neurons exposed to rote-
none, we measured the effect of two independent PKA inhibitors, H89
and Rp-8-Br-cAMPS (Lochner and Moolman, 2006) on mitochondrial
length in hucp2 expressing neurons exposed to rotenone. We found
thatmitochondrial length in hucp2 expressing neurons exposed to rote-
none was signiﬁcantly shortened in the presence of H89 or Rp-8-Br-
cAMPS, similar to that observed in control neurons treated with rote-
none (Fig. 8F; mitochondrial length: control + rot 1.3 μm ± 0.04;
hUCP2 + rot 1.86 μm ± 0.12; hUCP2 + rot + H89 1.26 μm ± 0.06;
hUCP2 + rot + Rp-8-Br-cAMPS 1.41 μm ±0.04; control + H89
1.33 μm± 0.05; control + Rp-8-Br-cAMPS 1.54 μm± 0.07; N = 31–
42). Taken together, these results indicate that mitochondrial fusion
events and elongated mitochondria maintained in hucp2 expressing
neurons exposed to rotenone require intact PKA activity.
Mitochondrial mobility is necessary for fusion events. To monitor
the effect of rotenone on mitochondrial movement, we generated ky-
mographs through time-lapse imaging of GFP labeled mitochondria in
neurites of primary DA neuron culture (Pham et al., 2012). We found
that controlmitochondria are rathermobile as displayed by diffused, di-
agonal tracks along the vertical time axis (Fig. 9A). In sharp contrast,
straight tracks showing little mitochondrial movement were recor-
ded in control neurons exposed to rotenone with a 26% decrease
in mitochondrial mobility (Figs. 9A&C, % mitochondrial mobility:
control 37 ± 3; control + FSK 57 ± 5.3; control + rot 11 ± 1.8; con-
trol + FSK + rot 39 ± 4.3; hUCP2 53.5 ± 4.7; hUCP2 + rot 45.4 ±
4.7; hUCP2 + rot + H89 4.3 ± 1.4; hUCP2 + rot + Rp-8-Br-
cAMPS 12.3 ± 1.3; N = 11–30). Interestingly, forskolin treatment
promoted mitochondrial mobility by 19% and effectively attenuated
rotenone-induced movement defects (Figs. 9B,D&I). To assess how
hUCP2 impacts onmitochondrial mobility, wemeasured a 15% increase
inmobility as the result of hucp2 expressionwhen compared to controls
(Figs. 9E&I). Consistent with its rescuing effect on rotenone-induced
mitochondrial fragmentation and impaired fusion events, hucp2 ex-
pressing neurons were resistant to rotenone-induced mitochondrial
immobility (Figs. 9F&I). Finally, conﬁrming our ﬁndings that the
hUCP2-PKA pathway promotes mitochondrial integrity to counter
rotenone toxicity, kymograph recordings showed that mitochondrial
mobility maintained in hucp2 expressing neurons exposed to rotenone
was blocked in the presence of H89 or Rp-8-Br-cAMPS (Figs. 9F–I). Ad-
ditional kymograph recordings demonstrating the effect of PKA
Fig. 7. Rotenone-inducedmitochondrial ﬁssion and cell death is attenuated in primary DA
neurons pretreated with a PKA activator, forskolin (FSK). (A–D) Representative images of
mitochondrial ﬁssion in a neuritic projection of control neurons (Cont) (A), control neu-
rons treated with FSK (20 μM for 8 h) (B), control neurons treated with rotenone (Rot)
(500 nM for 8 h) (C) and control neurons pretreated with FSK (20 μM) for 1 h followed
by Rot exposure (D) at 4 DIV. Scale bar= 5 μm. (E) Quantiﬁcation of mitochondrial length
under conditions A–D. Each bar represents average ± SEM. P values were calculated by
Student's t test. N = 31–42 images from three neuronal preparations. (F) DA neuron
loss following rotenone exposure was rescued by pretreating control neurons with 2 μM
FSK. Following 6 days of rotenone exposure, DA neurons were quantiﬁed as the number
of TH+ cells per 1000 DAPI+ cells (seeMaterials andmethods). Each bar represents av-
erage± SEM. P values were calculated by Student's t test. N = 4 experiments with a total
of 72–79 images quantiﬁed.
Fig. 8.Mitochondrial fusion in hucp2 expressing neurons exposed to rotenone requires in-
tact PKAactivity. (A)Quantiﬁcation ofmitochondrial fusion following photo-conversion of
mitochondrially localizedmitoDendra2 in neurites of primary DA neurons. Following pre-
treatment with the PKA activator forskolin (FSK) or inhibitor H89 for 1 h, neurons were
exposed to rotenone for 8 h before photo-conversion of selectedmitochondria and record-
ing of photo-converted mitochondria under each treatment condition undergoing fusion
within 30min. Each bar represents average± SEM. P values were calculated by Student's
t test. N= 3–4 neuron preparations with a total of 74–85mitochondria selected. Note the
same controls (±Rot) and hUCP2 + Rot described in Fig. 6B were included in (A) as they
were from the same experimental sets for relevant comparison. (B–F) Mitochondrial
lengthmaintained in hucp2 expressing primary DA neurons exposed to rotenone requires
PKA activity. (B–E) Representative images of mitochondrial morphology in neuritic pro-
jections of control neurons treatedwith rotenone (Cont+Rot) (B), hucp2 expressing neu-
rons treated with rotenone (hUCP2 + Rot) (C), hucp2 expressing neurons treated
with H89 and rotenone (hUCP2 + H89 + Rot) (D) or hucp2 expressing neurons treated
with Rp-8-Br-cAMPs and rotenone (hUCP2 + Rp-8-Br-cAMPS + Rot) (E) at 4 DIV. Scale
bar = 5 μm. (F) Quantiﬁcation of mitochondrial length under conditions B–E and in con-
trol neurons treated with PKA inhibitors. The Image J tool (NIH) was used to quantify the
average mitochondrial length (see Materials and methods). Each bar represents average
± S.E.M. P values were calculated by Student's t test. **P b 0.01 and ***P b 0.001 when
compared to controls. N = 3 experiments with a total of 31–42 images quantiﬁed. Rote-
none (Rot): 500 nM for 8 h. FSK + Rot: FSK (20 μM) for 1 h followed by rotenone
exposure; H89 + Rot: H89 (10 μM) for 1 h followed by rotenone exposure; Rp-8-Br-
cAMPS + Rot: Rp-8-Br-cAMPS (500 μM) for 1 h followed by rotenone exposure. Control:
THNw1118, UAS-mitoGFP; hUCP2: THNUAS-hucp2, UAS-mitoGFP.
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blocking forskolin effect are shown in Supplemental Fig. 5. Taken to-
gether, our results strongly suggest a role of the hUCP2-PKA pathway
in controlling mitochondrial mobility, fusion events and integrity to
counter rotenone toxicity.
hUCP2 neuroprotective effect against rotenone requires PKA
Extending the ﬁndings that PKA activity is required to maintain mi-
tochondrialmorphology and dynamics in hucp2 expressing neurons ex-
posed to rotenone, we examined whether PKA also functioned as an
effector to mediate increased survival in hucp2 expressing neurons ex-
posed to rotenone. To this end, we pretreated hucp2 expressing neurons
with H89 before exposing those neurons to rotenone followed by mea-
surements of annexin V binding to phosphatidylserine at the cell surfaceindicative of apoptotic death (Vermes et al., 1995). Consistent with the
results shown in Fig. 2, hucp2 expressing neurons had less annexin V
staining following rotenone treatment as compared to control neurons
under the same treatment. Importantly, rotenone-induced apoptosis
Fig. 9. Kymograph recordings illustrate that mitochondrial mobility blocked by rotenone
exposure is restored as the result of hUCP2 or PKA activity. Kymograph recordings illus-
trate abundantmitochondrial movements in a control neurite (A) that are blunted follow-
ing rotenone exposure at 4 DIV (C). Treatment of forskolin (FSK) induces a signiﬁcant
increase in mitochondria mobility (B) and rescues rotenone-induced movement defects
(D). Similar to FSK treatment, hucp2 expression promotes mitochondria mobility
(E) resulting in heightened resistance to rotenone-inducedmovement defects (F) that re-
quires PKA activity (G&H). Each representative image shows movements of GFP labeled
mitochondria recorded during 10 min of time-lapse imaging. The initial frame of each
live-imaging series is displayed above the kymograph generated from the movie. The x-
axis represents mitochondrial position. Over y-axis, diffused, diagonal tracks represent
movement ofmitochondria and straight tracks represent stationarymitochondria. (I) Per-
centage of mobile mitochondria quantiﬁed over a 10-min imaging period under each
condition. Each bar represents average ± S.E.M. P values were calculated by Student's
t test. N = 3 experiments with a total of 11–30 images quantiﬁed. Scale bar = 5 μm.
Rotenone (Rot): 500 nM for 8 h. Forskolin (FSK): 20 μM for 8 h. FSK + Rot: FSK (20 μM)
for 1 h followed by rotenone exposure. H89+ Rot: H89 (10 μM) for 1 h followed by rote-
none exposure. Rp-8-Br-cAMPS+Rot: Rp-8-Br-cAMPS (500 μM) for 1 h followed by rote-
none exposure. Control: THNw1118, UAS-mitoGFP; hUCP2: THNUAS-hucp2, UAS-mitoGFP.
Fig. 10. hUCP2 neuroprotective effect against rotenone requires PKA. (A–D) Representa-
tive images of rotenone-induced apoptosis in primary DA neurons are shown. Following
24 h of rotenone (500 nM) or vehicle (DMSO) treatment, GFP labeled DA neurons were
stainedwith Annexin V (Red) (Annexin V-CF594™, Biotium Inc.) and imaged using confo-
calmicroscopywith 60× oil objective lens and excitation at 488 nmand 560 nm. Differen-
tial interference contrast (DIC) images (B, D) corresponding to ﬂuorescent GFP and
Annexin V-CF594 staining (A, C) are shown. Arrows indicate DA neurons undergoing ap-
optosis. Scale bar= 10 μm. (E) Effect of rotenone treatment alone orwith H89 (10 μM) on
apoptosis of control andhUCP2 neurons. Apoptosis analysiswas performedon primaryDA
neurons following treatment with rotenone alone or H89 + rotenone for 24 h. Apoptotic
or pre-apoptotic cells were quantiﬁed as the proportion of GFP labeled DA neurons with
Annexin V staining (see Materials and methods). Each bar represents average ± S.E.M. P
values were calculated by Student's t test. N = 3 experiments with a total of 26–33
images quantiﬁed.
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treatment (Fig. 10E; % apoptosis; control: 9.4 ± 0.02; control + rot:
24.2 ± 0.02; hucp2 + rot: 14.5 ± 0.03; hucp2 + H89 + rot: 50 ±
0.1, N = 26–33). It is noteworthy that rotenone exposure rendered
higher apoptotic death in hucp2 expressing neurons pretreated with
H89 as compared to control neurons treated with rotenone. We ruledout a potential toxic effect of H89 as control neurons pretreated with
H89 had similar apoptotic events with (Fig. 10) or without rotenone
treatment (data not shown). Taken together, these results strongly sug-
gest that PKA activity is required in preserving cell survival in hucp2 ex-
pressing neurons exposed to rotenone.Discussion
The rotenonemodel reproduces PD associated pathology in rodents,
most notably Lewy body-like structure not achieved by either 6-
hydroxydopamine or MPTP administration (Perier et al., 2003). In
Drosophila, rotenone induced motor impairment is alleviated by L-
DOPA ingestion (Coulom and Birman, 2004). Given its utility in model-
ing sporadic PD, a complete understanding of rotenone toxic action will
likely have a signiﬁcant impact on novel neuroprotective strategies. We
previously reported that hucp2 expression in DA neurons protects those
neurons from rotenone-induced cell death in Drosophila (Islam et al.,
2012). In the current study, we demonstrate that modulation of mito-
chondrial dynamics has a profound inﬂuence in rotenone-induced DA
neurodegeneration in vivo and characterize a novel hUCP2-PKA path-
way in counteracting rotenone toxicity by maintaining mitochondrial
integrity and mobility associated with enhanced cell survival.
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tizes those neurons to rotenone-induced cell losswhereas increased ex-
pression of Marf or Opa1 engenders a protective effect. Using various
live-cell imaging techniques, we extensively characterized rotenone
toxicity on mitochondrial dynamics and morphology. In primary DA
neuron cultures treated with rotenone, we measured stagnant mito-
chondrialmovement, decreasedmitochondrial fusion events and short-
ened mitochondrial length. Consistent with the current understanding
that efﬁcient mitochondrial fusion process allows complementary
equilibration ofmatrixmetabolites, intactmtDNA copies andmitochon-
drial membrane constituents (Reviewed in Twig and Shirihai (2011))
whereas tipping mitochondrial dynamics towards ﬁssion advances cell
death (Frank et al., 2001; Yu et al., 2005), our in vivo and in vitroDAneu-
ron studies have substantiated a direct role of mitochondrial dynamics
inmodulating rotenone neurotoxicity. Recently, it was shown that lack-
ing mitochondrial fusion molecule Mfn2 in a subset of DA neurons in
mice results in mitochondrial fragmentation and also severely dimin-
ishes transport of the organelle leading to progressive nigrostriatal neu-
rodegeneration (Pham et al., 2012). As growing evidence has pointed to
an important role of Mfn2 in mitochondrial transport (Misko et al.,
2010), our ﬁndings of decreased mitochondrial mobility as the result
of rotenone exposure in primary DA neurons implicate that impaired
mitochondrial transport and subsequent energy deﬁciency in neuronal
terminals may be involved in rotenone neurotoxicity in vivo. Contrary
to our ﬁndings of stagnant mitochondrial movement following short-
term rotenone exposure, chronic rotenone treatment of primary cortical
neurons leads to increased retrograde mitochondrial transport (Arnold
et al., 2011). This discrepancy in mitochondrial movement in response
to rotenone between the two models is likely due to compensatory
mitochondrial homeostatic responses such as biogenesis not accounted
for in our model with acute rotenone exposure (Arnold et al., 2011).
As several neurotoxins including nitric oxide, MPP+ and rotenone
induce mitochondrial ﬁssion followed by cell death in vitro, future
in vivomodels could assess whether promoting mitochondrial fusion
and transport is a useful approach to counter toxin-induced DA
neurodegeneration.
Based on the ﬁndings that the mitochondrial fusion/ﬁssion machin-
ery modiﬁes rotenone toxicity, we were prompted to ask whether the
hUCP2 neuroprotective effect against rotenone involved mitochondrial
remodeling. Indeed, under rotenone treatment, we show that mito-
chondrial morphology and dynamics as well as cell survival are better
preserved in hucp2 expressing neurons as compared to control neurons.
Consistent with our genetic interaction studies indicating functional co-
operation between hUCP2 and the mitochondrial fusion pathway, we
detected more fused mitochondrial morphology in brain DA neurons
expressing hucp2 similar to that observed as the result of overexpres-
sion ofmitochondrial fusionmoleculeMarf or Opa1. These observations
are strongly corroborated by our in vitro ﬁndings, where hUCP2 activity
is associated with preserved mitochondrial fusion activity in neurons
exposed to rotenone. Consistentwith a higher number ofmitochondrial
fusion events recorded in hucp2 expressing neurons versus controls ex-
posed to rotenone, mitochondria are more elongated in these neurons.
This increased fusion activity is presumably facilitated by a better-
preserved mitochondrial mobility. As a result, elongated mitochondria
are more resistant to rotenone toxicity through maintaining a mito-
chondrial network for efﬁcient repair of damaged mitochondria (Twig
and Shirihai, 2011). Indeed, we show in Drosophila S2R+ cells that
hUCP2 activity renders those cells more resistant to rotenone-induced
mitochondrial depolarization, a strong indication of mitochondrial
health.
In an effort to elucidate the underlying mechanism whereby hUCP2
inﬂuences mitochondrial dynamics, we explored bioenergetic conse-
quences of increased mitochondrial uncoupling and identiﬁed cAMP-
dependent PKA as the novel downstream effector in restoring mito-
chondrial dynamics as well as cell survival in countering rotenone
toxicity. These ﬁndings are signiﬁcant as they explain at least in part,the hUCP2 neuroprotective mechanism. Furthermore, to our knowl-
edge, we have provided the ﬁrst evidence of a protective role for PKA
against rotenone in primary DA neurons. We show that rotenone asso-
ciated defects in mitochondrial morphology and mobility are signiﬁ-
cantly restored in the presence of a PKA activator, forskolin. Consistent
with its uncoupling activity, increased hUCP2 activity results in higher
cAMP levels in our S2R+ system, providing a plausible mechanism of
PKA activation. In line with our hUCP2-PKA model, we show that pre-
served mitochondrial length, fusion events andmovement in hucp2 ex-
pressing primary neurons exposed to rotenone require intact PKA
activity.
Among several modes of post-translational modiﬁcation in regulat-
ing Drp1 function, reversible phosphorylation at SerPKA by PKA serves
to inhibit mitochondrial ﬁssion (Chang and Blackstone, 2007; Cribbs
and Strack, 2007). During starvation and a concomitant rise of intracel-
lular cAMP levels, activation of PKA is shown to promote elongated mi-
tochondria to escape autophagy (Gomes et al., 2011). In a cellular PD
model, PKA targeted tomitochondria amelioratesmitochondrial defects
as the result of PINK1 deﬁciency, and these protective effects are mim-
icked by constitutive phosphorylation of Drp1 at SerPKA (Dagda et al.,
2011). To understand themechanismwhereby PKA affected Drp1 func-
tion, it was elegantly shown that Drp1 phosphorylation by PKA inhibits
the disassembly step of its catalytic cycle leading to accumulation of
large, non-functional Drp1 oligomers at the outer mitochondrial mem-
brane (Merrill et al., 2011). In these reports, steady-state elongated mi-
tochondrial morphology was measured as the result of PKA activation
or mitochondrial localization of PKA, which is associated with cell
survival against pro-apoptotic insults. In our study, we quantiﬁed
mitochondrial fusion events and determined that rotenone-induced im-
pairment of mitochondrial fusion is signiﬁcantly reversed in the
presence of forskolin. While our results suggest a possible role of PKA
in inﬂuencing mitochondrial fusion, additional study is required to
fully investigate whether PKA is involved in the mitochondrial fusion
process.
In thepresence of a PKA inhibitor,mitochondrial integrity, preserved
mitochondrial fusion events and mobility as well as enhanced survival
in hucp2 expressing primary DA neurons exposed to rotenone are abro-
gated. These results provide strong evidence for a novel UCP2-PKA axis
in neuroprotection against toxin rotenone. However, we did not detect
a signiﬁcant change inmitochondrial length or increasedmitochondrial
fusion in hucp2 expressing neurons under basal conditions. It is conceiv-
able that without external stress, mitochondrial morphology and dy-
namics are maintained by a homeostatic equilibrium of fusion and
ﬁssion events. In the presence of rotenonehowever,whenmitochondri-
al dynamics is shifted towards ﬁssion, UCP2-PKA activity mediated mi-
tochondrial fusion is effective in maintaining mitochondrial integrity
and cell survival. While our ﬁndings do not rule out additional protec-
tive mechanisms such as decreased oxidative stress as the result of
hucp2 expression, they provide a novel link between UCP2 activity
and preserved mitochondrial integrity through activation of PKA in
countering DA neuron toxin rotenone.
Drosophilamodels of rare familial forms of PD provided profound in-
sights into the physiological roles of PINK1 and Parkin in mitochondrial
remodeling and quality control (Greene et al., 2003; Poole et al., 2008;
Yang et al., 2008). Comparatively few advances have been made in uti-
lizing this genetic system to identify novel protective mechanisms
against toxin-related degeneration of DA neurons. We show that in
our in vivo and in vitro toxinmodels promoting elongatedmitochondria
counters rotenone mediated DA neurodegeneration. Moreover, we
demonstrate a novel hUCP2-PKA protective mechanism in DA neurons
against rotenone-induced mitochondrial ﬁssion and cell death thus
highlighting the importance of balanced mitochondrial dynamics in
DA neuron health. As increasing evidence identiﬁes inducible transcrip-
tional regulation of neuronal ucp expression, it is conceivable to develop
therapeutic strategies for PD by targeting UCP2 (reviewed in Ho et al.
(2012)).
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Generation and maintenance of ﬂy lines
The TH-Gal4 driver line was obtained from the Bloomington Stock
Center (Friggi-Grelin et al., 2003). The homozygous UAS-hucp2 ﬂy line
was previously shown to render neuroprotection in THNhUCP2 ﬂies
exposed to rotenone (Islam et al., 2012). The homozygous, double
transgenic UAS-hucp2; TH-Gal4 ﬂy line was generated via genetic
crosses followed by genomic PCR and qPCR analysis to conﬁrm hucp2
expression in ﬂy heads. The THNGFP line was a gift from Dr. S. Birman
(Dev. Biol. Institute of Marseille, France) and THNmitoGFP ﬂies were
provided by Dr. B. Lu (Stanford University). The UAS-Drp1, UAS-
Drp1K38A, UAS-Marf, UAS-Opa1, UAS-Parkin and UAS-PINK1 ﬂy lines
were kind gifts of Dr. J. Chung (Seoul National University, Korea).
The UAS-mitoDendra2 construct was generated based on a CMV-
mitoDendra2 construct (Wang et al., 2008). Following germ-line
transformation, several homozygous UAS-mitoDendra2 lines were gen-
erated and tested for expression. Homozygous, double transgenic
THNmitoDendra2 ﬂy lines were generated via genetic crosses followed
by imaging analysis of DA-speciﬁc expression of mitoDendra2. UAS-
Drp1RNAi (Stock# 27682), UAS-MarfRNAi (Stock# 31157) and UAS-
Opa1RNAi (Stock# 32358) lines were obtained from the Bloomington
Stock Center. GMRNhUCP2 double transgenic ﬂies were generated by
meiotic recombination. All ﬂy stocks were maintained in a humidiﬁed,
temperature-controlled incubator with 12 h on/off light cycle at 25 °C
on standard corn meal/yeast/sucrose/agar diet.
Chemicals
Rotenone, forskolin, H89 and Rp-8-Br-cAMPS were purchased from
Sigma (St. Louis, MO).
Isolation and culturing of primary DA neurons
Midgastrula embryos were collected and dechorionated in 50%
bleach solution. The embryonic contents were harvested and plated
on FluoroDish glass bottom dishes precoated with poly-D-lysine
(World Precision Instruments Inc., Sarasota, FL) as previously described
(Park and Lee, 2006; Park et al., 2007). Primary neuron cultureswere in-
cubated under 5% CO2 at 25 °C and maintained for up to 9 days in vitro
(DIV). Culturemedium(DDM1)used in this studywas amixture of high
glucose Ham's F-12/Dulbecco's medium (Irvine Scientiﬁc, Santa Ana,
CA), L-glutamine (2.5 mM; Irvine Scientiﬁc), HEPES (20 mM; Irvine
Scientiﬁc), and 4 supplements: 100 μM putrescine, 20 ng/ml progester-
one, 100 μg/ml transferrin, and 50 μg/ml insulin (Calbiochem, San
Diego, CA).
Immunoﬂuorescent staining and quantiﬁcation of TH+ primary neurons
Cell survival in control or hucp2 expressing neurons was measured
at 9 DIV. To measure rotenone-induced cell death, rotenone dissolved
in DMSOwas added to cultures at 3 DIV for 6 days before quantiﬁcation
of DA neurons. Primary neurons were ﬁxed with 4% paraformaldehyde
for 40min on ice. The cultures were washed 3 times with 10mMphos-
phate buffer solution (PBS). Blocking and permeabilization steps were
done by using 0.1% Triton X-100 and 5% goat serum (Sigma, St. Louis,
MO) for 30 min on ice. The permeablized cultures were incubated
with a primary anti-TH antibody (ImmunoStar Inc., WI) overnight
at 4 °C and then with a TRITC labeled secondary antibody (Jackson
ImmunoResearch Laboratories Inc., PA) for 1 h at 25 °C. After staining
was completed the cultures were washed 3 times for 10 min, then the
coverslipsweremounted on glass slides and viewedunder aﬂuorescent
microscope (Olympus IX71). Images were takenwith a Spot CCD digital
camera (Diagnostic Instruments, Sterling Heights, MI). To count total
cells in each image, DAPI (Molecular Probes, OR)was used as previouslydescribed (Park and Lee, 2006). In order to minimize the subjectivity in
manual cell counting,we used Image J software (http://rsb.info.nih.gov/
ij/index.html). A sample area in each image was chosen to calculate the
unit pixel intensity (UPI) for each cell. The UPI was obtained by dividing
the pixel intensity in a sample area with the manually counted number
of cells in that area (typically 30–60 cells). Then the total DAPI signal in-
tensity in an image was measured and divided by the UPI in order to
quantify the total number of DAPI+ cells in that image. Finally, the
number of TH+ DA neurons in that image was normalized to 1000
DAPI+ cells. A total of 72–79 images from three independent neuronal
preparations were counted.
Immunoﬂuorescent staining and quantiﬁcation of TH+ neurons in adult
brains
Ten-day-old ﬂieswere starved on 1% agar containing vials for 6 h be-
fore subjected to rotenone treatment in vials containing 1% agar mixed
with 5% sucrose and 500 μM rotenone for four–ﬁve days.Whole-mount
immunoﬂuorescent staining of adult brains was performed essentially
as described (Islamet al., 2012). Brieﬂy, followingﬁxation in 4%parafor-
maldehyde, adult brains were dissected and permeabilized with 1% Tri-
ton/PBS, blocked with 5% normal goat serum and immunoprobed with
an anti-TH antibody (ImmunoStar Inc., WI) at 4 °C for two days follow-
ed by incubation with a secondary antibody conjugated with TRITC
(Jackson ImmunoResearch Laboratories Inc., PA) for two hours at
25 °C. Following three washes in triton-containing PBS, the immuno-
stained brains were mounted on cover slips for confocal microscopy.
Z-series images with a 0.2 μm step size were captured with 60× oil
objective and TH+ DA neurons were quantiﬁed with a “blind”method
as described previously (Fridell et al., 2009). Essentially, each experi-
ment involved two people where one person performed the staining
and the other read the slides, which have been numerically “blinded”
by the ﬁrst person.
Confocal imaging and quantiﬁcation of mitochondrial morphology
To measure mitochondrial length, THNmitoGFP harboring primary
DA neurons were seeded onto poly-D-lysine-coated FluoroDish glass
bottom dishes as described above. All imaging experiments were per-
formed at 4 DIV in a well-equipped live-imaging chamber (Pathology
Devices LiveCell™) attached to the confocal stage with controlled 5%
CO2 content, humidity and constant temperature at 25 °C. A series of
projected z-section images was collected using Nikon A1R confocal mi-
croscope (Nikon, Inc.) equipped with a 60× immersion oil objective
lenswith additional digital zoom of 2×. Imageswere digitally processed
using Nikon NIS Element software. Otsu's method was used to generate
thresholded binary images. Tomeasuremitochondrial length, the parti-
cle analysis plugin in Image J was used and the length of the major axis
was used to deﬁnemitochondrial length. Due to variations inmitochon-
drial size within each ﬁeld imaged, mitochondrial length in each condi-
tion was determined by measuring the mean mitochondrial length in
each ﬁeld of view and at least 30 individual ﬁelds were analyzed for
each condition.
To analyze mitochondrial mobility, THNmitoGFP neurons were re-
corded using time-lapse imaging. Images were acquired every 10 s for
10 min under confocal microscopy with pinhole set at 2 airy units and
at minimum laser intensity to minimize laser-induced cellular damage.
Kymographs were created using Image J/Multiple Kymograph software
(NIH). Mitochondrial mobility was visualized by movement tracks
displayed in kymographs. Each track represents one mitochondrion.
Vertical tracks represent stationary mitochondria whereas diffused, di-
agonal tracks indicate movements of mitochondria (Deng et al., 2013).
Mitochondrial mobility was quantiﬁed by counting the percentage of
mitochondria thatmoved over a 10min imaging period. Amitochondri-
on was considered stationary if it remained immobile for the entire
190 R.-D. Hwang et al. / Neurobiology of Disease 69 (2014) 180–191recording period. Mitochondrion is labeled as a motile one if its dis-
placement was ≥5 μm.
Quantiﬁcation of mitochondrial fusion events
Following photo-conversion, quantiﬁcation of mitochondrial fusion
events was performed as described previously with slight modiﬁcation
(Berman et al., 2009). Imaging of THNmitoDendra2 harboring primary
neurons was performed using a Nikon A1R confocal microscope with
a live imaging station as described above. For imaging, ﬁelds containing
neuritic projection expressing MitoDendra2 were identiﬁed, and 3 to 6
mitochondria per ﬁeld were randomly selected for photo-conversion.
The selected mitochondria were photo-converted from green to red
ﬂuorescence by exposing highly zoomed area to 405-nm laser at 4% in-
tensity for 5 iterations. Time-lapse imaging was initiated immediately
after photo-conversion and frames were captured every 30 s for
30 min (60 images) with excitation at 488 and 560 nm. For all studies,
3–4 ﬁelds per dish and 2 replicate dishes per condition were evaluated
in each of four independent experiments. Mitochondrial fusion events
were quantiﬁed based on the diffusion of red ﬂuorescence from one
converted mitochondrion to another green, non-converted one, by a
manual review of captured images with treatment conditions blinded
to the analyzer. The proportion of mitochondrial fusion events was de-
termined by counting the number of photo-converted MitoDendra2-
labeledmitochondria undergoing fusion in a total population of the ran-
domly selected photo-converted mitochondria in all the selected ﬁelds
over the 30 min imaging period.
Apoptosis assays
THNGFP or THNGFP, hUCP2 harboring primary neurons grown on
FluoroDish glass bottom dishes were exposed to rotenone (500 nM) at
4 DIV for 24 h. To measure the effect of H89 on rotenone-induced apo-
ptosis, neuronswere pretreatedwithH89 for 1 h at 10 μM. Following ro-
tenone or H89 + rotenone treatment, GFP+ DA neurons were washed
two times with 1× Annexin V binding buffer, which was supplied with
the apoptosis detection kit (Biotium Inc., Hayward, CA) and then stained
with diluted Annexin V-CF™594 conjugated in 1× binding buffer to a
ﬁnal concentration of 0.25 μg/ml at 25 °C for 30 min. After staining
was completed, the neurons were washed once with 1× binding buffer
and imaged immediately. A z-series of optical sections with a 0.5 μm
step size was recorded using a confocal microscope (Nikon A1R). Red
ﬂuorescence of Annexin V stained phosphatidylserine (PS) on the cell
surface indicates apoptotic cells. For all studies, 15 ﬁelds per dish per
condition were evaluated in each of the three independent experi-
ments. The proportions of GFP+ DA neurons with Annexin V staining
were quantiﬁed.
S2R+ studies
Inducible pMT/hUCP2-GFP and pMT/GFP constructs were generated
with the pMT-puro expression plasmid (Addgene). The resulting con-
structs were veriﬁed by sequencing and stably transfected into S2R+
cells using standard procedures. Following Cu2+ induction (250 μM
for 24 h), mitochondrial localization of hUCP2-GFP was determined by
immunoﬂuorescent staining with an anti-GFP antibody (Santa Cruz,
CA) and mitotracker red (Life Technologies, NY). Cells were imaged
using confocal microscopy (Nikon A1R) with a 60× oil objective lens
plus 3× digital ampliﬁcation.
Intracellular cAMP levels were measured in pMT/GFP or pMT/
hUCP2-GFP harboring S2R+ cells using the Cyclic AMP XP Assay Kit ac-
cording to manufacturer's procedure (Cell Signaling Technology, MA).
Brieﬂy, cells grown in a 12-well plate (~1 × 106/well) were induced
with Cu2+ at 250 μM for 24 h prior to cell lysis and competitive
enzyme-linked immunoassay (EIA). Triplicate samples were measured
in each experiment with a total of four experiments performed.Real-time analysis of ΔΨm in pMT/GFP or pMT/hUCP2-GFP harbor-
ing cells was performed using the membrane sensor TMRE at 20 nM
(Molecular Probes, OR). Following Cu2+ induction, rotenone (50 nM)
or vehicle (DMSO) was added to cells. Cells were immediately imaged
every minute for 20 min with confocal microscopy using a 60× oil
objective lens plus 1.5× digital ampliﬁcation (Nikon A1R). Changes in
TMRE ﬂuorescence intensity were analyzed using the Image J software
(NIH). Three independent experiments were performed.
Quantitative real-time RT-PCR expression analysis
Total RNA was isolated from heads of 10-day-old females raised on
standard diet using the TRIzol method, and subsequent cDNA and
real-time RT-PCR experiments were performed as described previously
(Fridell et al., 2009). Two-three separate RNA preparations with tripli-
cates in each QPCR experiment were used to derive the mean ratios of
target gene expression against the reference genes GAPDH or Tubulin
with primers described previously (Fridell et al., 2009; Neretti et al.,
2009). The following primers with catalog numbers from SABiosciences
were used: Drp1 (PPD02066A-200), Marf (PPD00513A-200), and Opa1
(PPD04655A-200).
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